Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa

American Journal of Infection Control

Volumn 36, Issue 10, 2008, Pages

  Yakupogullari, Yusuf ^a   Otlu, Baris ^b   Dogukan, Muruvvet ^c   Gursoy, Canan ^b   Korkmaz, Ebru ^c   Kizirgil, Ahmet ^c   Ozden, Mehmet ^c   Durmaz, Riza ^b  

^a MALATYA STATE HOSPITAL   (Turkey)

^b INONU UNIVERSITY   (Turkey)

^c FIRAT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULPERAZON; VANCOMYCIN;

ADULT; AMPUTATION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIC; FEMALE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; LENGTH OF STAY; MALE; MORTALITY; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR;

ALGINATES; ANTI-BACTERIAL AGENTS; APACHE; CASE-CONTROL STUDIES; COLISTIN; CONFIDENCE INTERVALS; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HOSPITAL BED CAPACITY, 500 AND OVER; HOSPITALS, UNIVERSITY; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TURKEY;

EID: 57349086216     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2008.07.006     Document Type: Article

References (18)

1. Rossolini G.M., and Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect 4 (2005) 17-32
2. Thuong M., Arvaniti K., Ruimyz R., Salmoniere P., Scanvic-Hameg A., Lucet J.C., et al. Epidemiology of Pseudomonas aeruginosa and risk factors for carriage acquisition in an intensive care unit. J Hosp Infect 53 (2003) 274-282
3. Rosenthal V.D., Maki D.G., Salomao R., Alvarez-Moreno C., Mehta Y., and Higuera F. et al, and the International Nosocomial Infection Control Consortium. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 145 (2006) 582-591
4. Widmer A.F., Wenzel R.P., Trilla A., Bale M.J., Jones R.N., and Doebbeling B.N. Outbreak of Pseudomonas aeruginosa infections in a surgical intensive care unit: probable transmission via hands of a health care worker. Clin Infect Dis 16 (1993) 372-376
5. Livermore D.M. The threat from the pink corner. Ann Med 35 (2003) 1-9
6. Livermore D.M. Of pseudomonas, porins, pumps, and carabapenems. J Antimicrob Chemother 47 (2001) 247-250
7. Delissalde F., and Amabile-Cuevas C.F. Comparison of antibiotic susceptibility and plasmid content between biofilm-producing and non-producing clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 24 (2004) 405-408
8. Deplano A., Denis O., Poirel L., Hocquet D., Nonhoff C., Byl B., et al. Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J Clin Microbiol 43 (2005) 1198-1204
9. Hsueh P.R., Tseng S.P., Teng L.J., and Ho S.W. Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan. Clin Microbiol Infect 11 (2005) 670-673
10. Falagas M.E., Bliziotis I.A., Kasiakou S.K., Samonis G., Athanassopoulou P., and Michalopoulos A. Outcome of infections due to pandrug-resistant (PDR) gram-negative bacteria. BMC Infect Dis 8 (2005) 1-24
11. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections. Am J Infect Control 16 (1988) 128-140
12. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically: Approved Standard M7-A5. 5th ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002.
13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobic disc susceptibility tests: Approved Standard M2-A2 S2. Wayne, PA: National Committee for Clinical Laboratory Standards (1981)
14. O'Toole G.A., Pratt L.A., Watnick P.I., Newman D.K., Weaver V.B., and Kolter R. Genetic approaches to study biofilms. Methods Enzymol 310 (1993) 91-109
15. Barth A.L., and Pitt T.L. Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. J Clin Microbiol 33 (1995) 37-40
16. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
17. Brown M.L., Aldrich H.C., and Gauthier J.J. Relationship between glycocalyx and povidone-iodine resistance in Pseudomonas aeruginosa (ATCC 27853) biofilms. Appl Environ Microbiol 61 (1995) 187-193
18. Berlana D., Llop J.M., Fort E., Baida M.B., and Jodar R. Use of colistin in the treatment of multiple-drug-resistant gram-negative infections. Am J Health Syst Pharm 62 (2005) 39-47